Focal therapy for prostate cancer: precision with fewer side effects

By Andrew Tan, Urologist, Prostate & Kidney Surgeon, Nedlands

Over the past decade, the management of clinically significant, localised prostate cancer has undergone a significant evolution.

While radical prostatectomy and external beam radiotherapy remain the gold standards for many patients, the associated morbidity – particularly impacting sexual function and urinary continence – has prompted interest in less invasive strategies.

Focal therapy has emerged as a promising middle ground, offering the potential for effective cancer control with minimal impact on quality of life....

This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.

Existing Users Log In